Form 4 Tracker
Acumen Pharmaceuticals, Inc.
ABOS

26 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 5, 2026Jan 5 10:06 PMBarton Russell
Proposed Sale
4,000$1.96$7.8K

View →

Jan 5, 2026Jan 5 10:03 PMZuga Matt
Proposed Sale
4,000$1.96$7.8K

View →

Jan 5, 2026Jan 5 9:48 PMOConnell Daniel Joseph
Proposed Sale
4,649$1.97$9.2K

View →

Jan 23, 2025Jan 23 9:17 PMZuga Matt
Proposed Sale
28,902$1.72$49.6K

View →

Jan 21, 2025Jan 21 9:32 PMMeisner Derek M
Proposed Sale
3,418$1.59$5.4K

View →

Jan 21, 2025Jan 21 9:31 PMSiemers Eric
Proposed Sale
3,219$1.59$5.1K

View →

Jan 21, 2025Jan 21 9:29 PMBarton Russell
Proposed Sale
2,914$1.70$5.0K

View →

Jan 21, 2025Jan 21 9:25 PMZuga Matt
Proposed Sale
4,364$1.60$7.0K

View →

Jan 21, 2025Jan 21 9:24 PMOConnell Daniel Joseph
Proposed Sale
12,619$1.59$20.1K

View →

Jan 3, 2025Jan 3 11:16 PMMeisner Derek M
Proposed Sale
11,122$1.84$20.5K

View →

Jan 3, 2025Jan 3 11:04 PMSiemers Eric
Proposed Sale
10,859$1.85$20.0K

View →

Jan 3, 2025Jan 3 10:59 PMBarton Russell
Proposed Sale
7,636$1.86$14.2K

View →

Jan 3, 2025Jan 3 10:54 PMZuga Matt
Proposed Sale
13,235$1.84$24.4K

View →

Jan 3, 2025Jan 3 10:00 PMOConnell Daniel Joseph
Proposed Sale
47,778$1.84$87.9K

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 17, 2026Jun 17 9:10 PMDerrell PorterDirector
Option Exercise
13,040$1.070(D)

View →

Jun 15, 2026Jun 17 9:10 PMDerrell PorterDirector
Option Exercise
6,460$1.0713,040(D)

View →

Jun 3, 2026Jun 5 9:12 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
53,250$2.2953,250(I)

View →

Jun 3, 2026Jun 5 8:32 PMNathan B FountainDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 8:31 PMKimberlee C DrapkinDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 8:30 PMJohn A Stalfort IIIDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 8:30 PMDerrell PorterDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 8:29 PMJeffrey L. IvesDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 8:28 PMGeorge GolumbeskiDirector
Grant/Award
53,250$2.2953,250(D)

View →

Jun 3, 2026Jun 5 8:27 PMLaura StoppelDirector
Grant/Award
53,250$2.2953,250(D)

View →

Mar 6, 2026Mar 11 1:45 AMDerek M MeisnerChief Legal Officer & Corp Sec
Option Exercise
2,090$1.8571,048(D)

View →

Feb 27, 2026Mar 4 2:42 AMDerek M MeisnerChief Legal Officer & Corp Sec
Option Exercise
9,406$1.8573,138(D)

View →

Jan 28, 2026Jan 29 12:50 AMDerek M MeisnerChief Legal Officer & Corp Sec
Option Exercise
2,671$1.8582,544(D)

View →

Jan 26, 2026Jan 29 12:50 AMDerek M MeisnerChief Legal Officer & Corp Sec
Option Exercise
15,085$1.8585,215(D)

View →

Jan 20, 2026Jan 21 11:32 PMDaniel Joseph OconnellDirector, Chief Executive Officer
Grant/Award
450,000$1.86450,000(D)

View →

Jan 16, 2026Jan 21 11:32 PMMatt ZugaCFO & Chief Business Officer
Grant/Award
148,700$1.89148,700(D)

View →

Jan 16, 2026Jan 21 11:31 PMDerek M MeisnerChief Legal Officer & Corp Sec
Grant/Award
148,700$1.89148,700(D)

View →

Jan 16, 2026Jan 21 11:31 PMEric SiemersChief Medical Officer
Grant/Award
148,700$1.89148,700(D)

View →

Jan 16, 2026Jan 21 11:30 PMRussell BartonChief Operating Officer
Grant/Award
126,900$1.89126,900(D)

View →

Jan 16, 2026Jan 21 11:29 PMAmy SchacterleChief Regulatory Officer
Grant/Award
126,900$1.89126,900(D)

View →

Page 1 of 2

Next →